About
Joined the investment team as Principal in 2024. Previously Senior Director of Business Development & Licensing at Bayer Pharmaceuticals and worked in Boehringer Ingelheim's external innovation group and Roche R&D.
Deals · 1
Trellis BioscienceLed round
via AMR Action Fund · filed Jan 2026
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at AMR Action Fund
Bill Burns
Board Chair at AMR Action Fund
Carly Levine
Senior Associate at AMR Action Fund
Chris Sweeney
Executive Director, Communications and Media Relations at AMR Action Fund
Corinna Ruppli
Office Manager at AMR Action Fund
David Hellmuth
General Counsel and COO at AMR Action Fund
Deepali Patel
Director of International Policy at AMR Action Fund
Dorothy Maloney
Compliance Officer at AMR Action Fund
Henni-Karoliina Ropponen
Venture Analyst at AMR Action Fund